EC Number | Crystallization (Comment) | Organism |
---|---|---|
2.7.4.9 | molecular dynamics simulation of interaction with acyclic nucleoside analogue inhibitors. Key interaction of residue R95 and the distal substituent | Homo sapiens |
2.7.4.9 | molecular dynamics simulation of interaction with acyclic nucleoside analogue inhibitors. Key interaction of residue R95 and the distal substituent | Mycobacterium tuberculosis |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.4.9 | (Z)-1-(4-(thymin-1-yl)but-2-enyl)-1H-benzo[c,d]indol-2(1H)one | - |
Mycobacterium tuberculosis | |
2.7.4.9 | (Z)-2-(4-(5-bromouracil-1-yl)but-2-enyl)-1H-benzo[d,e] isoquinoline-1,3(2H)-dione | - |
Mycobacterium tuberculosis | |
2.7.4.9 | (Z)-2-(4-(thymin-1-yl)but-2-enyl)-1H-benzo[d,e]isoquinoline-1,3(2H)-dione | - |
Mycobacterium tuberculosis | |
2.7.4.9 | (Z)-2-(4-(thymin-1-yl)but-2-enyl)-2,3-dihydro-1H-benzo-[d,e]isoquinolin-1-one | - |
Mycobacterium tuberculosis | |
2.7.4.9 | (Z)-2-(4-(thymin-1-yl)but-2-enyl)-2H-naphtho[1,8 cd]isothiazole-1,1-dioxide | - |
Mycobacterium tuberculosis | |
2.7.4.9 | (Z)-2-(4-(thymin-1-yl)but-2-enyl)-6-nitrobenzo[c,d]indol-2(1H)one | - |
Mycobacterium tuberculosis | |
2.7.4.9 | additional information | acyclic nucleoside analogues (Z)-2-(4-(thymin-1-yl)but-2-enyl)-1H-benzo[d,e]isoquinoline-1,3(2H)-dione and (Z)-2-(4-(thymin-1-yl)but-2-enyl)-2,3-dihydro-1H-benzo-[d,e]isoquinolin-1-one are not inhibitory up to 0.02 mM | Homo sapiens | |
2.7.4.9 | thymidine | - |
Mycobacterium tuberculosis |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.7.4.9 | 0.0045 | - |
dTMP | - |
Homo sapiens | |
2.7.4.9 | 0.0045 | - |
dTMP | - |
Mycobacterium tuberculosis |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.4.9 | Homo sapiens | - |
- |
- |
2.7.4.9 | Mycobacterium tuberculosis | P9WKE1 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.4.9 | ATP + dTMP | - |
Homo sapiens | ADP + dTDP | - |
? | |
2.7.4.9 | ATP + dTMP | - |
Mycobacterium tuberculosis | ADP + dTDP | - |
? |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.7.4.9 | 0.00027 | - |
(Z)-2-(4-(thymin-1-yl)but-2-enyl)-2H-naphtho[1,8 cd]isothiazole-1,1-dioxide | pH 7.4 | Mycobacterium tuberculosis | |
2.7.4.9 | 0.00042 | - |
(Z)-1-(4-(thymin-1-yl)but-2-enyl)-1H-benzo[c,d]indol-2(1H)one | pH 7.4 | Mycobacterium tuberculosis | |
2.7.4.9 | 0.00075 | - |
(Z)-2-(4-(thymin-1-yl)but-2-enyl)-6-nitrobenzo[c,d]indol-2(1H)one | pH 7.4 | Mycobacterium tuberculosis | |
2.7.4.9 | 0.0011 | - |
(Z)-2-(4-(5-bromouracil-1-yl)but-2-enyl)-1H-benzo[d,e] isoquinoline-1,3(2H)-dione | pH 7.4 | Mycobacterium tuberculosis | |
2.7.4.9 | 0.0014 | - |
(Z)-2-(4-(thymin-1-yl)but-2-enyl)-2,3-dihydro-1H-benzo-[d,e]isoquinolin-1-one | pH 7.4 | Mycobacterium tuberculosis | |
2.7.4.9 | 0.0019 | - |
(Z)-2-(4-(thymin-1-yl)but-2-enyl)-1H-benzo[d,e]isoquinoline-1,3(2H)-dione | pH 7.4 | Mycobacterium tuberculosis | |
2.7.4.9 | 0.027 | - |
thymidine | pH 7.4 | Mycobacterium tuberculosis |